Abbvie Inc. (ABBV) SEC Filings — 2024
21 SEC filings for Abbvie Inc. (ABBV) in 2024.
Filings
- AbbVie Inc. Files 8-K: Director and Officer Changes — 8-K · Dec 13, 2024
- AbbVie Inc. Files Q3 2024 10-Q Financial Report — 10-Q · Nov 4, 2024
- AbbVie Inc. Files 8-K on Financials and Senior Notes — 8-K · Oct 30, 2024
- AbbVie Files 8-K on Financials and Senior Notes — 8-K · Oct 3, 2024
- AbbVie Inc. Files Routine 8-K Report — 8-K · Sep 10, 2024
- AbbVie Inc. Files Q2 2024 10-Q Report — 10-Q · Aug 7, 2024
- AbbVie Inc. Files 8-K on Financial Operations — 8-K · Jul 25, 2024
- AbbVie Inc. Files 8-K on Financials and Senior Notes — 8-K · Jul 3, 2024
- AbbVie Files 8-K/A: Director Changes and Officer Compensation — 8-K/A · May 8, 2024
- Abbvie Inc. 10-Q Filing — 10-Q · May 3, 2024
- AbbVie Files 8-K on Financials and Debt — 8-K · Apr 26, 2024
- AbbVie Inc. Files 8-K on Financial Operations — 8-K · Apr 3, 2024
- AbbVie Inc. Files Definitive Proxy Statement for 2024 Annual Meeting — DEF 14A · Mar 18, 2024
- AbbVie Details Senior Notes in Latest 8-K Filing — 8-K · Feb 26, 2024
- AbbVie 8-K Details Officer Changes, Compensation, and Debt Structure — 8-K · Feb 20, 2024
- AbbVie Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 20, 2024
- Abbvie Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- AbbVie 8-K: Rule 425 Filing Signals Potential Transaction — 8-K · Feb 12, 2024
- AbbVie 8-K Details Financial Condition, Senior Notes on Feb 2 — 8-K · Feb 2, 2024
- BlackRock Amends AbbVie Stake, Remains Key Institutional Holder — SC 13G/A · Jan 25, 2024
- AbbVie Updates on Financial Condition, Senior Notes Maturities — 8-K · Jan 5, 2024